MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/resp.13100

Медицинская библиотека · Respirology (Carlton, Vic.) · 2017

Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials.

Chen Wang-Chun, Huang Chi-Hsien, Sheu Chau-Chyun, Chong Inn-Wen, Chu Kuo-An, Chen Yung-Che, Tsai Jong-Rung, Lee Cheng-Hung, Wei Yu-Feng

СтатьяМетаанализСистематический обзорПеревод в очереди

Аннотация

Several long-acting bronchodilators have been developed and are widely used as first-line treatment in patients with stable chronic obstructive pulmonary disease (COPD). However, the initial choice of therapy is still uncertain. The aim of this study was to examine the clinical efficacy and safety of long-acting muscarinic antagonist (LAMA) and long-acting beta2-agonist (LABA) in patients with stable COPD. We searched several databases and manufacturers' websites to identify relevant randomized clinical trials for meta-analysis. Outcomes of interest were trough forced expiratory volume in 1 s (FEV1 ), acute exacerbations, transitional dyspnoea index (TDI) score, St George's Respiratory Questionnaire (SGRQ) score and adverse events. Sixteen trials with a total of 22 872 patients were included in this study. Compared with LABA, LAMA were associated with a greater reduction in acute exacerbations (OR: 0.84, 95% CI: 0.74-0.94, P = 0.003) and fewer adverse events (OR: 0.92, 95% CI: 0.86-0.97, P = 0.005). There were no significant differences in trough FEV1 , TDI and SGRQ scores. In patients with stable COPD, LAMA were associated with a greater reduction in acute exacerbations and fewer adverse effects compared with LABA.

Для цитирования: Chen Wang-Chun, Huang Chi-Hsien, Sheu Chau-Chyun, Chong Inn-Wen, Chu Kuo-An, Chen Yung-Che, Tsai Jong-Rung, Lee Cheng-Hung, Wei Yu-Feng. Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials.. Respirology (Carlton, Vic.). 2017. DOI: 10.1111/resp.13100.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.